Next Article in Journal
Effect of Bee Venom and Its Fractions on the Release of Pro-Inflammatory Cytokines in PMA-Differentiated U937 Cells Co-Stimulated with LPS
Previous Article in Journal
Vaccine Delivery Methods into the Future
Article Menu

Export Article

Open AccessReview
Vaccines 2016, 4(2), 10; doi:10.3390/vaccines4020010

Burkholderia cepacia Complex Vaccines: Where Do We Go from here?

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA
Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, TX 77555, USA
Author to whom correspondence should be addressed.
Academic Editor: Diane M. Harper
Received: 28 January 2016 / Revised: 7 April 2016 / Accepted: 8 April 2016 / Published: 15 April 2016
View Full-Text   |   Download PDF [482 KB, uploaded 15 April 2016]   |  


Burkholderia comprises a wide variety of environmental Gram-negative bacteria. Burkholderia cepacia complex (Bcc) includes several Burkholderia species that pose a health hazard as they are able to cause respiratory infections in patients with chronic granulomatous disease and cystic fibrosis. Due to the intrinsic resistance to a wide array of antibiotics and naturally occurring immune evasion strategies, treatment of Bcc infections often proves to be unsuccessful. To date, limited work related to vaccine development has been performed for Bcc pathogens. In this review, we have gathered key aspects of Bcc research that have been reported in recent years related to vaccine efforts, virulence, immune responses, and animal models, and use this information to inform the research community of areas of opportunity toward development of a viable Bcc vaccine. View Full-Text
Keywords: Burkholderia cepacia complex; vaccine; cystic fibrosis Burkholderia cepacia complex; vaccine; cystic fibrosis

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Pradenas, G.A.; Ross, B.N.; Torres, A.G. Burkholderia cepacia Complex Vaccines: Where Do We Go from here? Vaccines 2016, 4, 10.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top